Leveraging transcriptomics, Mendelian randomization, and double machine learning algorithm for causal biomarker discovery and prognostic signature development in the context of graphene-related lung adenocarcinoma.
Saved in:
| Title: | Leveraging transcriptomics, Mendelian randomization, and double machine learning algorithm for causal biomarker discovery and prognostic signature development in the context of graphene-related lung adenocarcinoma. |
|---|---|
| Authors: | Cao Z; The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China., Ma ML; Department of Oncology, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China., Xiao Y; The Second Affiliated Hospital of Guangdong Medical University, School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang, China., Zhang Y; The Second Affiliated Hospital of Guangdong Medical University, School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang, China., Chen Y; Department of Quality Management, Xiangyang Blood Center, Xiangyang, China., Zhu X; The Second Affiliated Hospital of Guangdong Medical University, School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang, China. |
| Source: | Computer methods in biomechanics and biomedical engineering [Comput Methods Biomech Biomed Engin] 2025 Dec 24, pp. 1-22. Date of Electronic Publication: 2025 Dec 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 9802899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-8259 (Electronic) Linking ISSN: 10255842 NLM ISO Abbreviation: Comput Methods Biomech Biomed Engin Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1476-8259 |
|---|---|
| DOI: | 10.1080/10255842.2025.2606227 |
